ALERCE INVESTMENT MANAGEMENT, L.P. Holdings

ALERCE INVESTMENT MANAGEMENT, L.P. is an investment fund managing more than 103.85M US dollars. The largest holdings include Annexon, American Well and Global Blood Therapeutics.

$103.85M

portfolio value

+8.27%

quarter

-60.30%

1 year

ALERCE INVESTMENT MANAGEMENT, L.P. portfolio changes

ALERCE INVESTMENT MANAGEMENT, L.P. 13F holdings

Stock	Position type	Portfolio share	Portfolio value	Avg. open price	Current price	P/L	Last change
Biotechnology Annexon, Inc. Portfolio share: 26.24% Portfolio value: 27.24M Avg. open price: $3.77 Current price: $5.74 P/L: +52.25% Bought +125.53% shares Q3 2022	share	26.24%	27.24M	$3.77	$5.74	+52.25%	Bought +125.53% shares Q3 2022
Health Information Services American Well Corporation Portfolio share: 24.55% Portfolio value: 25.49M Avg. open price: $4.32 Current price: $3.75 P/L: -13.19% Bought +12.70% shares Q3 2022	share	24.55%	25.49M	$4.32	$3.75	-13.19%	Bought +12.70% shares Q3 2022
Biotechnology Global Blood Therapeutics, Inc. Portfolio share: 23.36% Portfolio value: 24.26M Avg. open price: $31.95 Current price: $68.49 P/L: +114.37% Bought +182.15% shares Q3 2022	share	23.36%	24.26M	$31.95	$68.49	+114.37%	Bought +182.15% shares Q3 2022
Biotechnology Aadi Bioscience, Inc. Portfolio share: 17.62% Portfolio value: 18.29M Avg. open price: $12.32 Current price: $13.42 P/L: +8.89% Bought +245.47% shares Q3 2022	share	17.62%	18.29M	$12.32	$13.42	+8.89%	Bought +245.47% shares Q3 2022
Biotechnology Assembly Biosciences, Inc. Portfolio share: 3.52% Portfolio value: 3.65M Avg. open price: N/A Current price: $1.32 P/L: N/A N/A Q4 2020	share	3.52%	3.65M	N/A	$1.32	N/A	N/A Q4 2020
Biotechnology Aileron Therapeutics, Inc. Portfolio share: 3.31% Portfolio value: 3.43M Avg. open price: $1.04 Current price: $2.79 P/L: +168.27% Bought +118.27% shares Q1 2021	share	3.31%	3.43M	$1.04	$2.79	+168.27%	Bought +118.27% shares Q1 2021
Biotechnology Akebia Therapeutics, Inc. Portfolio share: 1.42% Portfolio value: 1.47M Avg. open price: N/A Current price: $0.29 P/L: N/A N/A Q4 2020	share	1.42%	1.47M	N/A	$0.29	N/A	N/A Q4 2020

Showing TOP 7 ALERCE INVESTMENT MANAGEMENT, L.P.'s 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of ALERCE INVESTMENT MANAGEMENT, L.P.?

The biggest position of the ALERCE INVESTMENT MANAGEMENT, L.P. is Annexon, Inc. (ANNX) with 26.24% portfolio share worth of 27.25M US dollars.

Top 5 ALERCE INVESTMENT MANAGEMENT, L.P.'s holdings represent 95.28% of the portfolio:

Annexon, Inc. (ANNX) – 26.24%
American Well Corporation (AMWL) – 24.55%
Global Blood Therapeutics, Inc. (GBT) – 23.36%
Aadi Bioscience, Inc. (AADI) – 17.62%
Assembly Biosciences, Inc. (ASMB) – 3.52%

Who is the portfolio manager of ALERCE INVESTMENT MANAGEMENT, L.P.?

The portfolio manager of the ALERCE INVESTMENT MANAGEMENT, L.P. is .

What is the total asset value of the ALERCE INVESTMENT MANAGEMENT, L.P. portfolio?

ALERCE INVESTMENT MANAGEMENT, L.P. total asset value (portfolio value) is 103.85M US dollars.

Who is ?

is the portfolio manager of the ALERCE INVESTMENT MANAGEMENT, L.P..

What is (ALERCE INVESTMENT MANAGEMENT, L.P.) fund performance?

ALERCE INVESTMENT MANAGEMENT, L.P.'s quarterly performance is +8.27%, annualy -60.30%.

What is the ALERCE INVESTMENT MANAGEMENT, L.P. CIK?

ALERCE INVESTMENT MANAGEMENT, L.P.'s Central Index Key is 0001844002 .